What Procriar does

Procriar is a private fertility clinic headquartered in Porto, Portugal, specializing in the diagnosis and treatment of infertility. The clinic operates from a single location on Avenida da Boavista and serves a diverse patient base including heterosexual couples, female same-sex couples, single women, women seeking fertility preservation, and international patients from Europe, North America, and South America. Procriar has been ISO 9001 certified since its founding, positioning itself as a compliance-grade provider of reproductive medicine services.

The clinic's core technology stack includes Embryoscope time-lapse incubators with AI-powered embryo selection algorithms (used in all treatments), vitrification techniques (first Portuguese clinic to achieve Kitazato's Best Practice Recognition), and preimplantation genetic testing (PGT-A, PGT-M, PGT-SR) with compatibility screening for up to 2,200 autosomal recessive diseases. Procriar operates one of Portugal's largest open-identity (non-anonymous) gamete donor banks with detailed donor profiles, serving both its own patient treatments and supplying donor gametes to other Portuguese PMA centers and EU sperm banks. The team is led by Clinical Director Dr. Joana Mesquita Guimarães and includes subspecialists in reproductive medicine, genetics, andrology, anesthesiology, embryology, psychology, and dedicated multilingual patient managers.

Procriar operates on a direct-to-patient pay-as-you-go pricing model, with treatment cycles priced individually (IVF/ICSI at €5,250, egg donation at €7,900, IUI at €990, egg freezing at €3,100, ROPA at €5,550) and all advanced technologies included without additional charges. Revenue streams include fertility treatment services, egg/oocyte cryopreservation, PGT services, and B2B gamete supply. The go-to-market combines sales-led patient management with a free initial consultation offer, online booking, educational content marketing, and a dedicated international patient program that coordinates travel, accommodation, and visa logistics for overseas patients.

Name

Procriar

Legal name

Procriar

Website

https://procriar.pt

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Procriar is a Porto-based fertility clinic offering IVF, ICSI, egg/sperm donation, PGT, and egg freezing, serving heterosexual couples, female same-sex couples, single women, and international patients across Europe and the Americas.

Ownership category

akta.pro rank

Product category

Fertility Clinic Services

NAICS

Family Planning Centers (621410)

akta.pro primary industry

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)

akta.pro secondary industries

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD), Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA)

Keywords

• Assisted reproductive technology
• Fertility clinic services
• In vitro fertilization
• Gamete donation programs
• Preimplantation genetic testing

Headquarters

HQ city

Coimbra

HQ country

Portugal

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Fertility Treatment Services: Revenue generated from medical procedures including IVF, ICSI, egg donation, sperm donation, ROPA/shared motherhood, IUI, and testicular biopsy. Treatment cycles are priced individually with transparent pricing. Additional costs include medication, clinical analyses, embryo storage, and additional embryo transfers.
2. Egg/Oocyte Cryopreservation: Egg freezing service including collection, vitrification, and initial storage for up to 5 years. Separate from IVF treatments.
3. Preimplantation Genetic Testing (PGT): Genetic testing services for embryos including PGT-A (aneuploidy screening), PGT-M (monogenic diseases), and PGT-SR (structural rearrangements). Billed per embryo tested.
4. Donor Gametes: Supply of donor sperm and oocytes to other PMA centers in Portugal. Also provides donor gametes for own treatments.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Procriar operates a fertility study center in Porto, Portugal, offering assisted reproduction treatments including in vitro fertilization (IVF), ICSI, egg and sperm donation, intrauterine insemination, preimplantation genetic testing (PGT), oocyte cryopreservation, the ROPA shared-motherhood method, and testicular biopsy. The clinic runs one of Portugal's largest open-identity gamete donor banks and serves both domestic and international patients.

Product overview

Procriar is a fertility clinic offering a comprehensive portfolio of assisted reproductive technology treatments. The clinic provides a complete range of services including IVF (In Vitro Fertilization), ICSI (Intracytoplasmic Sperm Injection), egg and sperm donation programs, intrauterine insemination (IUI), egg freezing (cryopreservation), preimplantation genetic testing (PGT-A, PGT-M, PGT-SR), ROPA/shared motherhood for lesbian couples, and testicular biopsy procedures. The clinic operates a large open-identity donor bank with detailed profiles and genetic compatibility testing capabilities. All treatments utilize advanced technologies including Embryoscope® time-lapse incubators with AI-powered embryo selection algorithms.

Differentiator

Problem solved

Functional benefit

Products and services

• In Vitro Fertilization (IVF)
• ICSI (Intracytoplasmic Sperm Injection)
• Egg and Sperm Donation
• Intrauterine Insemination (IUI)
• Preimplantation Genetic Testing (PGT)
• Oocyte Cryopreservation (Egg Freezing)
• ROPA Method (Shared Motherhood)
• Testicular Biopsy

Quantifiable outcome

• 70-80% probability of at least one live birth for women under 38 who freeze 15-20 mature oocytes
• +2 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• KitazatocoreTechnology or IntegrationKitazato is the world leader in vitrification technology for reproductive medicine. Procriar was the first Portuguese clinic to receive Kitazato's Best Practice Recognition in Vitrification certification, demonstrating excellence in egg/oocyte cryopreservation techniques.
• Renowned International Genetics LaboratoriescoreTechnology or IntegrationProcriar collaborates with world-renowned genetics laboratories for PGT (Preimplantation Genetic Testing) analysis, ensuring cells obtained during biopsy procedures are analyzed rigorously and informatively. The clinic also works with Professor Sérgio Castedo, a prestigious Portuguese medical geneticist.
• International Sperm Banks (EU)coreChannel Partner/ Reseller/ DistributorProcriar works with international sperm banks within the European Union, in addition to its own sperm bank. These partnerships expand donor options for patients while maintaining compliance with Portuguese legislation on non-anonymous donation.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Institut Marquès: Barcelona-based fertility clinic with strong international patient program serving France, UK, Italy, and Latin America; matches Procriar's multilingual, technology-forward positioning.
• IVI-RMA Global: World's largest IVF clinic network (formerly IVI in Spain, merged with RMA US; owned by KKR) with deep Iberian presence and full-service fertility offering matching Procriar's IVF/ICSI/donation/PGT/cryopreservation stack.
• GeneraLife: Pan-European fertility clinic platform (Italy/Spain/Portugal) providing the same IVF, ICSI, donor programs, and PGT — competes head-to-head for Iberian cross-border fertility patients.
• Ginemed: Spanish/Portuguese fertility clinic group offering IVF, ICSI, egg/sperm donation, PGT and shared motherhood (ROPA) — a direct Iberian competitor with overlapping ROPA treatment positioning.
• Bourn Hall Clinic: UK fertility clinic originator with deep IVF heritage, offering IVF, ICSI, donor programs, and fertility preservation — comparable in full-service breadth and international patient flows.
• CREATE Fertility: UK-based fertility chain known for mild-stimulation and natural-cycle IVF; overlapping patient segments with Procriar and competes for international self-pay patients.
• Virtus Health: ASX-listed global fertility clinic operator with Australian and international footprint, offering IVF/ICSI/donor services and advanced embryology analogous to Procriar.
• TFP (The Fertility Partnership): European fertility clinic network with sites in UK, Netherlands, Poland, Denmark, and Germany; comparable donor-program and international patient model to Procriar.
• Monash IVF: ASX-listed Australian fertility clinic group with full IVF/ICSI/donation suite and proprietary EmbryoGen/PGT lab capabilities; directly comparable vertically integrated fertility offering.
• Genea: Australian-headquartered global fertility clinic chain with proprietary embryology technology (Geri time-lapse) — directly comparable as a tech-forward, full-service fertility network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/procriarclinica
• Instagraminstagram.com/procriarclinica

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Procriar